دورية أكاديمية

Automated Non-Sterile Pharmacy Compounding: A Multi-Site Study in European Hospital and Community Pharmacies with Pediatric Immediate Release Propranolol Hydrochloride Tablets.

التفاصيل البيبلوغرافية
العنوان: Automated Non-Sterile Pharmacy Compounding: A Multi-Site Study in European Hospital and Community Pharmacies with Pediatric Immediate Release Propranolol Hydrochloride Tablets.
المؤلفون: Sandler Topelius, Niklas, Shokraneh, Farnaz, Bahman, Mahsa, Lahtinen, Julius, Hassinen, Niko, Airaksinen, Sari, Verma, Soumya, Hrizanovska, Ludmila, Lass, Jana, Paaver, Urve, Tähnas, Janika, Kern, Catharina, Lagarce, Frederic, Fenske, Dominic, Malik, Julia, Scherliess, Holger, Cruz, Sara P., Paulsson, Mattias, Dekker, Jan, Kammonen, Katja
المصدر: Pharmaceutics; May2024, Vol. 16 Issue 5, p678, 28p
مصطلحات موضوعية: HOSPITAL pharmacies, EUROPEAN communities, PROPRANOLOL, SPECIALTY pharmacies, NEAR infrared spectroscopy, DRUGSTORES, QUALITY control
مصطلحات جغرافية: EUROPE
مستخلص: Pharmacy compounding, the art and science of preparing customized medications to meet individual patient needs, is on the verge of transformation. Traditional methods of compounding often involve manual and time-consuming processes, presenting challenges in terms of consistency, dosage accuracy, quality control, contamination, and scalability. However, the emergence of cutting-edge technologies has paved a way for a new era for pharmacy compounding, promising to redefine the way medications are prepared and delivered as pharmacy-tailored personalized medicines. In this multi-site study, more than 30 hospitals and community pharmacies from eight countries in Europe utilized a novel automated dosing approach inspired by 3D printing for the compounding of non-sterile propranolol hydrochloride tablets. CuraBlend® excipient base, a GMP-manufactured excipient base (pharma-ink) intended for automated compounding applications, was used. A standardized study protocol to test the automated dosing of tablets with variable weights was performed in all participating pharmacies in four different iterative phases. Integrated quality control was performed with an in-process scale and NIR spectroscopy supported by HPLC content uniformity measurements. In total, 6088 propranolol tablets were produced at different locations during this study. It was shown that the dosing accuracy of the process increased from about 90% to 100% from Phase 1 to Phase 4 by making improvements to the formulation and the hardware solutions. The results indicate that through this automated and quality controlled compounding approach, extemporaneous pharmacy manufacturing can take a giant leap forward towards automation and digital manufacture of dosage forms in hospital pharmacies and compounding pharmacies. [ABSTRACT FROM AUTHOR]
Copyright of Pharmaceutics is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:19994923
DOI:10.3390/pharmaceutics16050678